The work of delivering innovative therapies to patients must be done well and quickly. This became the leadership mantra for Nevine Zariffa, former Head of Biometrics and Information Sciences at AstraZeneca, following her personal battle with cancer. Diagnosed with chronic myeloid leukemia (CML) at 33, Zariffa's cancer has been in remission for 25 years thanks to an investigational drug she received through a compassionate use clinical trial.

In this episode, Zariffa joins Alex to discuss the evolution of AI in the pharmaceutical industry. She emphasizes the importance of a strong connection between business leaders and data scientists in scaling AI projects. Tune in to discover Zariffa’s formula for effective change management and her insights on the future of AI in pharma and health tech.